Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain: Clinical Implications
- PMID: 27199787
- PMCID: PMC4852181
- DOI: 10.3389/fpsyt.2016.00080
Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain: Clinical Implications
Abstract
Over the past two decades, a steeply growing number of persons with chronic non-cancer pain have been using opioid analgesics chronically to treat it, accompanied by a markedly increased prevalence of individuals with opioid-related misuse, opioid use disorders, emergency department visits, hospitalizations, admissions to drug treatment programs, and drug overdose deaths. This opioid misuse and overdose epidemic calls for well-designed randomized-controlled clinical trials into more skillful and appropriate pain management and for developing effective analgesics that have lower abuse liability and are protective against stress induced by chronic non-cancer pain. However, incomplete knowledge regarding effective approaches to treat various types of pain has been worsened by an under-appreciation of overlapping neurobiological mechanisms of stress, stress-induced relapse to opioid use, and chronic non-cancer pain in patients presenting for care for these conditions. This insufficient knowledge base has unfortunately encouraged common prescription of conveniently available opioid pain-relieving drugs with abuse liability, as opposed to treating underlying problems using team-based multidisciplinary, patient-centered, collaborative-care approaches for addressing pain and co-occurring stress and risk for opioid use disorder. This paper reviews recent neurobiological findings regarding overlapping mechanisms of stress-induced relapse to opioid misuse and chronic non-cancer pain, and then discusses these in the context of key outstanding evidence gaps and clinical-treatment research directions that may be pursued to fill these gaps. Such research directions, if conducted through well-designed randomized-controlled trials, may substantively inform clinical practice in general medical settings on how to effectively care for patients presenting with pain-related distress and these common co-occurring conditions.
Keywords: addiction; addiction treatment; chronic pain; opiate addiction; opiate dependence; opioid dependence; substance use disorder; substance use disorders.
Similar articles
-
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.Pain Physician. 2017 Feb;20(2S):S93-S109. Pain Physician. 2017. PMID: 28226333 Review.
-
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).Pain Physician. 2017 Feb;20(2S):S111-S133. Pain Physician. 2017. PMID: 28226334
-
Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.Pain Med. 2015 Oct;16 Suppl 1:S3-8. doi: 10.1111/pme.12904. Epub 2015 Sep 11. Pain Med. 2015. PMID: 26360931 Review.
-
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1. MMWR Surveill Summ. 2015. PMID: 26469747
-
Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.Pain Physician. 2012 Jul;15(3 Suppl):ES67-92. Pain Physician. 2012. PMID: 22786463 Review.
Cited by
-
Hemokinin-1 is a mediator of chronic restraint stress-induced pain.Sci Rep. 2023 Nov 16;13(1):20030. doi: 10.1038/s41598-023-46402-7. Sci Rep. 2023. PMID: 37973885 Free PMC article.
-
The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models.Biol Psychiatry. 2020 Jan 1;87(1):54-63. doi: 10.1016/j.biopsych.2019.07.027. Epub 2019 Aug 6. Biol Psychiatry. 2020. PMID: 31521334 Free PMC article. Review.
-
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity.J Med Chem. 2020 May 28;63(10):5119-5138. doi: 10.1021/acs.jmedchem.9b01924. Epub 2020 Mar 23. J Med Chem. 2020. PMID: 31913038 Free PMC article.
-
Advances in the characterization of negative affect caused by acute and protracted opioid withdrawal using animal models.Neuropharmacology. 2023 Jul 1;232:109524. doi: 10.1016/j.neuropharm.2023.109524. Epub 2023 Mar 30. Neuropharmacology. 2023. PMID: 37003572 Free PMC article. Review.
-
Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework.Neurobiol Stress. 2018 Aug 11;9:84-104. doi: 10.1016/j.ynstr.2018.08.003. eCollection 2018 Nov. Neurobiol Stress. 2018. PMID: 30238023 Free PMC article. Review.
References
-
- Kowalczyk WJ, Phillips KA, Jobes ML, Kennedy AP, Ghitza UE, Agage DA, et al. Clonidine maintenance prolongs opioid abstinence and decouples stress from craving in daily life: a randomized controlled trial with ecological momentary assessment. Am J Psychiatry (2015) 172:760–7.10.1176/appi.ajp.2014.14081014 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous